Using high titer West Nile intravenous immunoglobulin from selected Israeli donors for treatment of West Nile virus infection

BMC Infectious Diseases

Volumn 9, Issue , 2009, Pages

  Ben Nathan, David ^a,b   Gershoni Yahalom, Orly ^a   Samina, Itzchak ^b   Khinich, Yevgeny ^b   Nur, Israel ^c   Laub, Orgad ^c   Gottreich, Ahuva ^d   Simanov, Michael ^b   Porgador, Angel ^a   Rager Zisman, Bracha ^a   Orr, Nadav ^c  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b KIMRON VETERINARY INSTITUTE   (Israel)

^c Omrix Biopharmaceuticals   (Israel)

^d Tel Hashomer   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; IMMUNOGLOBULIN; OMR IGG AM; UNCLASSIFIED DRUG; VIRUS ANTIBODY; IMMUNOGLOBULIN G;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ARTICLE; BLOOD DONOR; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENTIATION; ENDEMIC DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNOSUPPRESSIVE TREATMENT; ISRAEL; MOUSE; NONHUMAN; SURVIVAL RATE; VIRUS INFECTION; WEST NILE FLAVIVIRUS; ANIMAL; BAGG ALBINO MOUSE; BLOOD; CERCOPITHECUS; HUMAN; IMMUNOLOGY; PASSIVE IMMUNIZATION; SERODIAGNOSIS; VERO CELL;

ANIMALS; ANTIBODIES, VIRAL; BLOOD DONORS; CERCOPITHECUS AETHIOPS; FEMALE; HUMANS; IMMUNIZATION, PASSIVE; IMMUNOGLOBULIN G; IMMUNOGLOBULINS, INTRAVENOUS; ISRAEL; MICE; MICE, INBRED BALB C; NEUTRALIZATION TESTS; VERO CELLS; WEST NILE FEVER; WEST NILE VIRUS;

EID: 63049115215     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-9-18     Document Type: Article

References (34)

1. Keller MA Stiehm ER Passive immunity in prevention and treatment of infectious diseases Clin Microbiol Rev 2000, 13:602-614. 88952 11023960 10.1128/CMR.13.4.602-614.2000
2. Casadevall A Dadachova E Pirofski LA Passive antibody therapy for infectious diseases Nat Rev Microbiol 2004, 2:695-703. 10.1038/ nrmicro974 15372080
3. Smithburn KC Hughes TP Burke AW Paul JH A neutrotropic virus isolated from the blood of a native of Uganda Am J Trop Med 1940, 20:471-492.
4. Burke SD Monath TP Flaviviruses Fields Virology Philadelphia: Lippincott-Raven Field BN, Knipe DM, Howley PM 2001
5. Scherret JH Poidinger M Mackenzie JS Broom AK Deubel V Lipkin WI Briese T Gould EA Hall RA The relationships between West Nile and Kunjin viruses Emerg Infect Dis 2001, 7:697-705. 11585535
6. Nash D Mostashari F Fine A Miller J O'Leary D Murray K Huang A Rosenberg A Greenberg A Sherman M et al The outbreak of West Nile virus infection in the New York City area in 1999 N Engl J Med 2001 344 1807 1814 10.1056/NEJM200106143442401 11407341
7. Carson PJ Konewko P Wold KS Mariani P Goli S Bergloff P Crosby RD Long-term clinical and neuropsychological outcomes of West Nile virus infection Clin Infect Dis 2006, 43:723-730. 10.1086/506939 16912946
8. Debiasi RL Tyler KL West Nile virus meningoencephalitis Nat Clin Pract Neurol 2006, 2:264-275. 10.1038/ncpneuro0176 16932563
9. Hayes EB Gubler DJ West Nile virus: Epidemiology and clinical features of an emerging epidemic in the United States Annu Rev Med 2006, 57:181-194. 10.1146/annurev.med.57.121304.131418 16409144
10. Hayes EB Komar N Nasci RS Montgomery SP O'Leary DR Campbell GL Epidemiology and transmission dynamics of West Nile virus disease Emerg Infect Dis 2005, 11:1167-1173. 16102302
11. Glass WG McDermott DH Lim JK Lekhong S Yu SF Frank WA Pape J Cheshier RC Murphy PM CCR5 deficiency increases risk of symptomatic West Nile virus infection J Exp Med 2006, 203:35-40. 2118086 16418398 10.1084/ jem.20051970
12. Yakub I Lillibridge KM Moran A Gonzalez OY Belmont J Gibbs RA Tweardy DJ Single nucleotide polymorphisms in genes for 2′-5′-oligoadenylate synthetase and RNase L inpatients hospitalized with West Nile virus infection J Infect Dis 2005, 192:1741-1748. 10.1086/497340 16235172
13. Agrawal AG Petersen LR Human immunoglobulin as a treatment for West Nile virus infection J Infect Dis 2003, 188:1-4. 10.1086/376871 12825164
14. Diamond MS Development of effective therapies against West Nile virus infection Expert Rev Anti Infect Ther 2005, 3:931-944. 10.1586/ 14787210.3.6.931 16307506
15. Morrey JD Siddharthan V Olsen AL Roper GY Wang H Baldwin TJ Koenig S Johnson S Nordstrom JL Diamond MS Humanized monoclonal antibody against West Nile virus envelope protein administered after neuronal infection protects against lethal encephalitis in hamsters J Infect Dis 2006, 194:1300-1308. 10.1086/508293 17041857
16. Hamdan A Green P Mendelson E Kramer MR Pitlik S Weinberger M Possible benefit of intravenous immunoglobulin therapy in a lung transplant recipient with West Nile virus encephalitis Transpl Infect Dis 2002, 4:160-162. 10.1034/j.1399-3062.2002.01014.x 12421462
17. Shimoni Z Niven MJ Pitlick S Bulvik S Treatment of West Nile virus encephalitis with intravenous immunoglobulin Emerg Infect Dis 2001, 7:759. 11585547
18. Ben-Nathan D Lustig S Tam G Robinzon S Segal S Rager-Zisman B Prophylactic and therapeutic efficacy of human intravenous immunoglobulin in treating West Nile virus infection in mice J Infect Dis 2003, 188:5-12. 10.1086/376870 12825165
19. Planitzer CB Modrof J Kreil TR West Nile virus neutralization by US plasma-derived immunoglobulin products J Infect Dis 2007, 196:435-440. 10.1086/519392 17597458
20. Steele KE Linn MJ Schoepp RJ Komar N Geisbert TW Manduca RM Calle PP Raphael BL Clippinger TL Larsen T et al Pathology of fatal West Nile virus infections in native and exotic birds during the 1999 outbreak in New York City, New York Vet Pathol 2000, 37:208-224. 10.1354/vp.37-3-208 10810985
21. Ben-Nathan D Lustig S Kobiler D Cold stress-induced neuroinvasiveness of attenuated arboviruses is not solely mediated by corticosterone Arch Virol 1996, 141:1221-1229. 10.1007/BF01718826 8774683
22. Reed LJ Muench H A simple method of estimating fifty percent end points Am J Hyg 1938, 27:493-497.
23. Mahy BWJ Kangro HO Whole cells antigen preparations London: Academic Press, Harcourt Brace & Company 1996
24. Martin DA Muth DA Brown T Johnson AJ Karabatsos N Roehrig JT Standardization of immunoglobulin M capture enzyme-linked immunosorbent assays for routine diagnosis of arboviral infections J Clin Microbiol 2000, 38:1823-1826. 86599 10790107
25. Frey A Di Canzio J Zurakowski D A statistically defined endpoint titer determination method for immunoassays J Immunol Methods 1998, 221:35-41. 10.1016/S0022-1759(98)00170-7 9894896
26. Moynagh PN Toll-like receptor signalling pathways as key targets for mediating the anti-inflammatory and immunosuppressive effects of glucocorticoids J Endocrinol 2003, 179:139-144. 10.1677/joe.0.1790139 14596665
27. Casadevall A Passive antibody administration (immediate immunity) as a specific defense against biological weapons Emerg Infect Dis 2002, 8:833-841. 12141970
28. Engle MJ Diamond MS Antibody prophylaxis and therapy against West Nile virus infection in wild-type and immunodeficient mice J Virol 2003, 77:12941-12949. 296058 14645550 10.1128/JVI.77.24.12941-12949.2003
29. Haley M Retter AS Fowler D Gea-Banacloche J O'Grady NP The role for intravenous immunoglobulin in the treatment of West Nile virus encephalitis Clin Infect Dis 2003, 37:e88-90. 10.1086/377172 12955669
30. Roehrig JT Staudinger LA Hunt AR Mathews JH Blair CD Antibody prophylaxis and therapy for flavivirus encephalitis infections Ann N Y Acad Sci 2001, 951:286-297. 11797785
31. Oliphant T Engle M Nybakken GE Doane C Johnson S Huang L Gorlatov S Mehlhop E Marri A Chung KM et al Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus Nat Med 2005, 11:522-530. 1458527 15852016 10.1038/nm1240
32. Halevy M Akov Y Ben-Nathan D Kobiler D Lachmi B Lustig S Loss of active neuroinvasiveness in attenuated strains of West Nile virus: pathogenicity in immunocompetent and SCID mice Arch Virol 1994, 137:355-370. 10.1007/BF01309481 7944955
33. Gould LH Sui J Foellmer H Oliphant T Wang T Ledizet M Murakami A Noonan K Lambeth C Kar K et al Protective and therapeutic capacity of human single-chain Fv-Fc fusion proteins against West Nile virus J Virol 2005, 79:14606-14613. 1287547 16282460 10.1128/JVI.79.23.14606-14613.2005
34. Mateo R Xiao SY Guzman H Lei H Da Rosa AP Tesh RB Effects of immunosuppression on West Nile virus infection in hamsters Am J Trop Med Hyg 2006, 75:356-362. 16896148